News & Updates
Filter by Specialty:
GLP-1RA users face no elevated risk of pancreatic cancer
Among individuals with type 2 diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) does not contribute to increased pancreatic cancer risk, according to a study.
GLP-1RA users face no elevated risk of pancreatic cancer
16 Jan 2024
Inhaled amikacin cuts VAP burden in mechanically ventilated patients
In critically ill patients who have been on invasive mechanical ventilation (IMV) for at least 3 days, a subsequent 3-day course of preventive inhaled amikacin reduced the burden of ventilator-associated pneumonia (VAP) during 28 days of follow-up, findings from the AMIKINHAL trial have shown.
Inhaled amikacin cuts VAP burden in mechanically ventilated patients
16 Jan 2024
Xanomeline–trospium beneficial in treatment of schizophrenia
Treatment with the combination of xanomeline plus trospium leads to favourable reduction in positive and negative symptoms in patients with schizophrenia, while being well tolerated, according to data from the phase III EMERGENT-2 trial.
Xanomeline–trospium beneficial in treatment of schizophrenia
16 Jan 2024
Tricyclic antidepressant for IBS worth a try
The tricyclic antidepressant amitriptyline, when used at low dose in the second-line treatment setting and titrated according to symptom response and side-effects, is safe and provides relief from symptoms of irritable bowel syndrome (IBS), as shown in the phase III ATLANTIS* trial.
